Disparate LDL phenotypic classification among 4 different methods assesing LDL particle characteristics

Clinical Chemistry

Volumn 52, Issue 9, 2006, Pages 1722-1727

  Ensign, Wayne ^a   Hill, Nicole ^b   Heward, Christopher B ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Kronos Science Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; FEMALE; GEL ELECTROPHORESIS; GRADIENT GEL ELECTROPHORESIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PHENOTYPE; TUBE GEL ELECTROPHORESIS; ULTRACENTRIFUGATION;

ADULT; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL, LDL; CLINICAL CHEMISTRY TESTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PARTICLE SIZE; PHENOTYPE;

EID: 33748302787     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.059949     Document Type: Article

References (33)

1. Griffin BA. Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc 1999;58:163-9.
2. Brown MS, Faust JR, Goldstein JL. Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts. J Clin Invest 1975;55:783-93.
3. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-7.
4. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:357-64.
5. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 1981;78:6499-503.
6. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease [Review]. Clin Chem 1988;34:B78-83.
7. Fruchart JC, Packard CJ. Is cholesterol the major lipoprotein risk factor in coronary heart disease? A Franco-Scottish overview. Curr Med Res Opin 1997;13:603-16.
8. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984;76:4-12.
9. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
10. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992;12:187-95.
11. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994;5:395-403.
12. Frohlich JJ, Seccombe DW, Pritchard PH. The role of apoproteins in disorders of lipoprotein metabolism. Clin Biochem 1989;22:51-6.
13. Slyper AH. Low-density lipoprotein density and atherosclerosis: unraveling the connection. JAMA 1994;272:305-8.
14. Krauss RM. Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr 2001;131:340S-3S.
15. Krauss RM, Siri PW. Metabolic abnormalities: triglyceride and low-density lipoprotein. Endocrinol Metab Clin North Am 2004;33:405-15.
16. Ensign WY. Association of regional and total body composition, plasma lipids, lipoproteins, apolipoproteins and the effects of long-term resistance training in premenopausal females [PhD dissertation], AZ: University of Arizona, 1993.
17. Lamon-Fava S, McNamara JR, Farber HW, Hill NS, Schaefer EJ. Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon. Metabolism 1989;38:921-5.
18. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993;92:141-6.
19. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N. Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reduction. Metabolism 2004;53:733-9.
20. Krauss RM, Blanche PJ. Detection and quantitatlon of LDL subfractions. Curr Opin Lipidol 1992;3:377-83.
21. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
22. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986;128:417-31.
23. Lee DM, Downs D. A quick and large-scale density gradient subfractionation method for low density lipoproteins. J Lipid Res 1982;23:14-27.
24. Kulkarni KR, Garber DW, Jones MK, Segrest JP. Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology. J Lipid Res 1995;36:2291-302.
25. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
26. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, et al. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 1986;128:181-209.
27. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992;38:1632-8.
28. Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001;47:266-74.
29. Cooper GR, Myers GL, Smith SJ, Sampson EJ. Standardization of lipid, lipoprotein, and apolipoprotein measurements [Review]. Clin Chem 1988;34:B95-105.
30. Cloey T, Bachorik PS, Becker D, Finney C, Lowry D, Sigmund W. Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA 1990;263:2788-9.
31. Dormans TP, Swinkels DW, de Graaf J, Hendriks JC, Stalenhoef AF, Demacker PN. Single-spin density-gradient ultracentrifugation vs gradient gel electrophoresis: two methods for detecting low-density-lipoprotein heterogeneity compared. Clin Chem 1991;37:853-8.
32. McNamara JR, Campos H, Ordovas JM, Wilson PW, Schaefer EJ. Gradientgel electrophoresis analysis of low density lipoprotein. Am Biotechnol Lab 1988;6:28-33.
33. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb 1993;13:427-34.